Search results
Results from the WOW.Com Content Network
Endo Pharmaceuticals Holdings was created as a result of a $277 million management buyout of the division from DuPont Merck in 1997, led by Carol Ammon. [6] Through the merger with Algos, it changed name again to Endo Pharmaceuticals Holdings Inc. and began trading as a public company. [9]
Biotech firm Endo Health Solutions announced in a press release recently that it has named former Valeant Pharmaceuticals President Rajiv De Silva as the company's new CEO, replacing retiring CEO ...
In 2014, Endo Pharmaceuticals, an American pharmaceutical company, acquired most of the assets of Paladin Labs for $3 billion, or $151 a share, a 100 times increase from its IPO price. [5] As part of the transaction, Knight Therapeutics was spun-off to the shareholders of Paladin, with the rights to Impavido, a leishmaniasis drug. [6]
Endo will ask a U.S. bankruptcy judge to approve the sale and allow the company to emerge from bankruptcy at a March 19 court hearing, the DOJ added. Drugmaker Endo reaches $465 million bankruptcy ...
The following is a list of chief executive officers of notable companies. The list also includes lead executives with a position corresponding to chief executive officer (CEO), such as managing director (MD), and any concurrent positions held. Companies with a revenue of at least US$ 10 billion are included in the list.
Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less ...
There's no foolproof way to know the future for Endo Pharmaceuticals Holdings (NAS: ENDP) or any other company. However, certain clues may help you see potential stumbles before they happen -- and ...
He led the company's largest group, Human Health, from 2007 until he was named president of Merck in April 2010. [7] [16] On January 1, 2011, he became CEO and a member of the company's board of directors, replacing former Merck CEO Richard Clark. [7] [17] Frazier is the first African-American to lead a major pharmaceutical company. [5]